We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Microgen | LSE:MCGN | London | Ordinary Share | GB00BVVHWX30 | ORD 6 3/7P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 367.50 | 365.00 | 370.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
11/1/2010 14:28 | Thanks for the reply Rivaldo. As long as it's only those plonkers on Alphaville. I think they said sell at 80p ish, now 103p. Ref: AFR, see RNS dated 12/01/10. Nothing to be worried about asset wise. | cupra kid | |
11/1/2010 10:28 | 16k bought this morning at 92p. Cupra Kid, just in the course of reading FT Alphaville in particular I've noticed some broker doubts about the worth of AFR's assets. I don't know enough about AFR to say any more I'm afraid. | rivaldo | |
08/1/2010 21:12 | Rivaldo, I would be interested to know the broker/general negativity towards AFR? From my research I only hear good things that will continue to get better. | cupra kid | |
05/1/2010 14:24 | That will do - I thought volume like that would shift the share price if it were selling. | greenroom78 | |
05/1/2010 14:18 | More likely just institutional re-shuffling between funds or something given the stable share price. Might be more trades still to be reported. Nice to see such large holdings being shufled around at these levels. | rivaldo | |
05/1/2010 13:04 | Is somebody offloading? 350k @90p | greenroom78 | |
04/1/2010 09:58 | Hi Greenroom, happy new year to you. Will take a look at SKR. I'm afraid I've seen a fair amount of broker and general negativity about AFR, so not entirely convinced! Re AYM, they own 50% of LIM quoted in Canada, whose price has spiked up recently on various bits of good news re their iron ore properties which will start producing this summer. AYM is undervalued purely on this 50% stake, but also its Parys Mountain assets in Wales are in for free and may soon become very valuable given the recovery in metals prices. Nice to see MCGN blue on the first day of the year. | rivaldo | |
29/12/2009 14:34 | Rivaldo - just coincidence, happen to be around at same time (another quick one) I work at my computer with monitor open so can see new posts as well. I have had AYM on my monitor for a couple or three months and watched it slowly tick down. Nice rise recently though, what has brought that on? I was apprehensive about buying a spike but did look into them a fair bit before, they own quite a chunk of LIM if i'm correct (are they on the canadian exchange)? It now looks like they are holding on to the rise, and provided it doesn't rocket beforehand I might look at a bit more in the new year as funds become available. Again thanks for the tips and you work on MCGN. If you want a tip in return (although don't trust me!) I am hoping for big things from SKR & AFR this year. SKR are phospate mining in kazahkstan (AIM listed), have just had tests proving DAP production is possible. They expect to make profit from flour production for first time in 2010 (estimated EPS 6.5p), have no debt worries and are about to undertake BFS for possible funding/JV for DAP production plant. AFR are oil exloration/productio Please though DYOR, NAI Thanks again and good luck for 2010 | greenroom78 | |
29/12/2009 14:15 | Truffle, it's hardly a rush - MCGN called off their offer for SSY in April'08! MCGN have been selling in parcels over time, which given that the SSY holding is non-core seems only sensible. Greenroom78, that was a quick reply! Re ISAble shares, AYM looks extremely good imo for 2010 assuming the iron ore price continues to improve. I ISAd a load at 13p-15p so am well up, but AYM could go to, well, anything once its (or its subsidiary LIM's) mine comes on stream next year and/or its other assets not currently in the price become recognised. Looks like some VLE stock is available at present. That won't last for ever. I also commend a look at LOQ (on AIM), which is starting to move upwards. | rivaldo | |
29/12/2009 11:37 | Still not sure why MCGN would sell out of SSY in such a rush when the outlook for SSY looks pretty positive, based on their recent report. Better, surely, to sell on a scale-up basis over time? | truffle | |
28/12/2009 19:41 | Thanks Rivaldo, will take a look. I did have a bit of a look at VLE a few weeks back but was concerned there may be a bit of a retrace after missing the rise from 180p although has consolidated well. I did note it is another AIM share and I am trying to cut back on things I can't put in my ISA. I won't rule it out and will definately look at it further. | greenroom78 | |
28/12/2009 19:29 | No probs Greenroom78. Hope you had a good one. CHNS looks appealing on a historic P/E of 5.8 and maybe a lot less, with global growth prospects and what should be high recurring income. As for GKP, well I just can't see much downside now, whereas upside is large and relatively short-term assuming the oil price remains stable. As for something different, my two humungously undervalued holdings (imo!) are GNG and VLE. GNG is a close relative to MCGN, i.e: - high-tech, specialising in ECM - extremely high recurring income - fantastic Balance Sheet, i.e £4.5m net cash and £12m or so of net tangible assets, plus £2m PAT, against a £14m m/cap - enormous growth potential - the bluest of blue chip customer lists. i.e Lenovo, Huawei, Dell, Sony, VW, Air China, China Mobile etc etc, who are all locked in to using GNG's systems for the forseeable future (GNG have NEVER lost a customer). GNG are Chinese, as you may have guessed, so it's up to you whether you perceive this as being a problem. I've met the management and do not. My other big undervaluation is VLE. It has a £14m m/cap, yet has around £23m net cash plus businesses worth around say another £7m-£9m contributing £1m of annualised profit. Take a look at the VLE thread header post for details. | rivaldo | |
24/12/2009 08:45 | Thanks for all your MCGN updates Rivaldo and happy xmas to you. Hope to join you in CHNS soon, and hope GKP works out for us both. Any 2010 tips you have I'm all ears. | greenroom78 | |
24/12/2009 08:27 | Hi Boadicea - snap re CAR! All held in my ISAs and safely tucked away. If you look back through the RNS's you'll see that MCGN made an offer for SSY which SSY rejected. MCGN were therefore left with the holding they'd built up, but they've made a decent profit on it over time from memory. As you say, SSY is AIM-listed, whereas MCGN has the ISAbility advantage. I also love MCGN given the big cash pile, high recurring income and global prospects from increased financial regulation of banks etc. SSY's always looked a bit expensive to me, but I'll look again. A happy and healthy Xmas to you and all MCGN'ers. | rivaldo | |
23/12/2009 21:32 | Hi rivaldo - I noted from the SSY RNS today that MCGN had sold down their SSY holding. I wondered why they were doing this just as SSY appeared to have turned the corner and issued "ahead of expectation" news. In fact, I was left wondering how it came about that MCGN ever had an interest in SSY at all! Have MCGN had SSY in view as a target at some time - or is there another explanation? If such thoughts are now off their agenda it would explain the divestment of the holding in order to persue other targets with a lowly valuation (such as FSG???). Anyway, the SSY share price recovery seems to have been held back by the MCGN sales so I have doubled up on my modest holding there as I quite like the sound of recent developments. In addition to contract wins and qualification approvals, Its improved profitability arises in part from the lower value of the pound (much of its sales are to the Euro zone) and I expect that to contiunue. At the same time, perhaps MCGN deserves consideration as, unlike SSY, it is ISAable which is where my remaining spare funds now lie (even after the last top-up in CAR which after recent weeks' accelerating sp, makes it my largest holding by a margin.) | boadicea | |
23/12/2009 12:47 | RNS today - MCGN have sold their SSY holding down to below 3% from almost 1m shares. The year end Balance Sheet cash pile should continue to look very good, with SSY disposal proceeds partly replenishing the special divi payout. | rivaldo | |
22/12/2009 12:33 | Nice upwards trend on the chart - keeps bouncing upwards. | rivaldo | |
10/12/2009 08:14 | Did MCGN get into the FTSE All Share, anyone know? | truffle | |
09/12/2009 10:17 | Some large buys going through this morning 2x 200k & 3x 50k. | greenroom78 | |
08/12/2009 11:49 | I see MCGN have sold 700,000 SSY shares and are down to around 1m shares now, worth almost £500k. That will have brought in around £300,000. As fast as MCGN pay out special dividends they get more dosh in! | rivaldo | |
03/12/2009 23:08 | CapGemini ("a $10 billion global leader in consulting"!) are recruiting people with Microgen Aptitude experience - looks like their risk management teams are being expanded: | rivaldo | |
02/12/2009 14:19 | Good point Greenroom78, should be down only 4p given the special divi. Could be a buying opportunity. | rivaldo | |
02/12/2009 09:06 | The typical drop on XD day. Few people selling - hope they're not selling the drop. | greenroom78 | |
01/12/2009 13:38 | This is about as bullish as it gets: "Dec 01, 2009 08:00 ET Microgen Expands North American Presence to Support Demand for Its Technology Platform Adds Boston Office, Appoints U.S.-Based SVP BOSTON, MA--(Marketwire - December 1, 2009) - Microgen today announced that as part of its ongoing North American expansion strategy, it has opened an office in Boston and appointed Tom Crawford, as Senior Vice President for North America. Tom joined Microgen in 2003 and was most recently Managing Director of Microgen's Financial Services division. The Boston office is Microgen's second office in North America, where its U.S. headquarters are in New York. The changes follow 18 months of significant growth and success in the U.S. and Canada, where Microgen's clients include some of the world's largest financial services institutions and digital media companies. Microgen's success in North America has been driven by the success of Microgen Aptitude, the company's flagship business process management (BPM) platform, and the Microgen Accounting Hub (MAH). Microgen has developed MAH using Microgen Aptitude, as a product that can be rapidly implemented to satisfy the requirements of financial organizations to facilitate consistent global accounting. "Having set a strong foundation through new customer wins and project implementation success, we are excited to continue our growth in North America," said Senior Vice President Tom Crawford. "With the addition of our Boston office, we are now positioned to support our customers in their long-term success using Microgen's world-class technologies." Microgen Aptitude is a rules-based BPM platform that enables companies to manage very high volumes of information and complex processes, including reporting and decision automation, system integration and human workflow/exception management. The Microgen Accounting Hub is built on the Microgen Aptitude architecture and provides financial organizations with the ability to manage and process vast volumes of data at high speeds, providing a clear and transparent view of risk and liquidity and enabling financial executives to make smarter strategic decisions. "Further expansion into the North American market remains a key part of our global growth strategy," noted Microgen Chief Operating Officer David Sherriff. "We are very pleased to have Tom Crawford providing leadership on the ground to help broaden our geographical reach, as well as continue to deliver the very best services and technologies to existing customers in this region." " | rivaldo |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions